Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
- 13 October 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 43 (5), 417-422
- https://doi.org/10.1038/bmt.2008.334
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Impact of early relapse after auto-SCT for multiple myelomaBone Marrow Transplantation, 2008
- One or two autografts for myeloma?Blood, 2008
- Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trialBlood, 2008
- Management of multiple myeloma: The changing landscapeBlood Reviews, 2007
- High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 yearsBone Marrow Transplantation, 2007
- International uniform response criteria for multiple myelomaLeukemia, 2006
- Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myelomaCancer, 2006
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaNew England Journal of Medicine, 2003
- Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?Bone Marrow Transplantation, 1998